Wing Leung

14.3k total citations
206 papers, 8.0k citations indexed

About

Wing Leung is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Wing Leung has authored 206 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Hematology, 85 papers in Immunology and 64 papers in Oncology. Recurrent topics in Wing Leung's work include Hematopoietic Stem Cell Transplantation (100 papers), Immune Cell Function and Interaction (68 papers) and T-cell and B-cell Immunology (35 papers). Wing Leung is often cited by papers focused on Hematopoietic Stem Cell Transplantation (100 papers), Immune Cell Function and Interaction (68 papers) and T-cell and B-cell Immunology (35 papers). Wing Leung collaborates with scholars based in United States, Hong Kong and China. Wing Leung's co-authors include Ching‐Hon Pui, Dario Campana, Raul C. Ribeiro, Rupert Handgretinger, Hiroto Inaba, Jeffrey E. Rubnitz, Victoria Turner, Ashok Srinivasan, Barbara Rooney and Rekha Iyengar and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Wing Leung

196 papers receiving 7.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wing Leung 3.8k 3.5k 2.9k 1.8k 1.2k 206 8.0k
Peter Bader 5.3k 1.4× 2.6k 0.7× 2.6k 0.9× 2.2k 1.2× 1.1k 0.9× 270 8.9k
John E. Levine 6.1k 1.6× 3.8k 1.1× 2.2k 0.7× 1.2k 0.7× 868 0.7× 201 9.5k
Pierre Bordigoni 3.7k 1.0× 2.1k 0.6× 1.9k 0.7× 1.3k 0.7× 890 0.7× 203 8.0k
Nancy Bunin 2.6k 0.7× 2.1k 0.6× 4.6k 1.6× 1.4k 0.8× 805 0.7× 141 8.0k
Michael A. Pulsipher 4.5k 1.2× 1.5k 0.4× 2.4k 0.8× 2.1k 1.2× 1.2k 1.0× 253 7.6k
Chitra Hosing 5.1k 1.4× 2.2k 0.6× 3.2k 1.1× 1.2k 0.6× 435 0.4× 372 8.9k
Kirk R. Schultz 5.0k 1.3× 1.8k 0.5× 1.3k 0.5× 2.6k 1.4× 1.2k 1.0× 214 7.4k
Christina Peters 4.1k 1.1× 1.2k 0.3× 2.1k 0.7× 2.2k 1.2× 1.4k 1.1× 242 8.2k
Peter Dreger 5.4k 1.4× 3.2k 0.9× 4.6k 1.6× 1.0k 0.6× 677 0.6× 408 11.6k
Jürgen Finke 6.9k 1.8× 3.4k 1.0× 3.8k 1.3× 2.0k 1.1× 510 0.4× 396 12.9k

Countries citing papers authored by Wing Leung

Since Specialization
Citations

This map shows the geographic impact of Wing Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wing Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wing Leung more than expected).

Fields of papers citing papers by Wing Leung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wing Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wing Leung. The network helps show where Wing Leung may publish in the future.

Co-authorship network of co-authors of Wing Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Wing Leung. A scholar is included among the top collaborators of Wing Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wing Leung. Wing Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Seng, Michaela Su-Fern, Shui Yen Soh, Francesca Lim, et al.. (2025). Manufacturing Characteristics and Early Outcomes of a Tandem aCD22-aCD19 CAR-T Therapy for Childhood and Adult Relapsed/Refractory Acute Precursor B Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 31(2). S11–S11. 1 indexed citations
3.
4.
Ng, King Pan, Michaela Su-Fern Seng, & Wing Leung. (2025). Optimization of hypo-alloimmunogenic multispecific CAR-T and SARS-CoV-2-specific T cells for off-the-shelf adoptive cell therapy. Molecular Therapy — Methods & Clinical Development. 33(2). 101462–101462. 1 indexed citations
5.
Tsang, Hing Wai, Gilbert T. Chua, Keith T. S. Tung, et al.. (2025). The protective role of vitamin D in BNT162b2 vaccine-related acute myocarditis. Frontiers in Immunology. 16. 1501609–1501609. 1 indexed citations
6.
Leung, Wing, et al.. (2024). Efficient Edge-AI Models for Robust ECG Abnormality Detection on Resource-Constrained Hardware. Journal of Cardiovascular Translational Research. 17(4). 879–892. 9 indexed citations
7.
Seng, Michaela Su-Fern, King Pan Ng, Thuan Tong Tan, et al.. (2024). A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection. Cytotherapy. 26(10). 1170–1178. 1 indexed citations
8.
Teherani, Mehgan, Shanmuganathan Chandrakasan, Ann E. Haight, et al.. (2023). Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(12). 778.e1–778.e6. 1 indexed citations
9.
Browne, Emily, Anusha Sunkara, Guolian Kang, et al.. (2020). Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial. Journal of Pediatric Oncology Nursing. 37(6). 390–397. 2 indexed citations
10.
Federico, Sara M., M. Beth McCarville, Barry L. Shulkin, et al.. (2017). A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma. Clinical Cancer Research. 23(21). 6441–6449. 114 indexed citations
11.
Fernández, Lucía, Adela Escudero, María Vela, et al.. (2017). Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells. Clinical Cancer Research. 23(19). 5824–5835. 83 indexed citations
12.
Malki, Monzr M. Al, Mary M. Horowitz, Rupert Handgretinger, et al.. (2016). Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium—Haplo2014, San Francisco, California, December 4, 2014. Biology of Blood and Marrow Transplantation. 22(4). 594–604. 7 indexed citations
13.
Roberts, Kathryn G., Deqing Pei, Dario Campana, et al.. (2014). Outcomes of Children With BCR-ABL1 –Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease. Journal of Clinical Oncology. 32(27). 3012–3020. 165 indexed citations
14.
Rujkijyanont, Piya, Wing Keung Chan, Paul W. Eldridge, et al.. (2013). Ex Vivo Activation of CD56+ Immune Cells That Eradicate Neuroblastoma. Cancer Research. 73(8). 2608–2618. 20 indexed citations
15.
Inaba, Hiroto, Elaine Coustan‐Smith, Xueyuan Cao, et al.. (2012). Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia. Journal of Clinical Oncology. 30(29). 3625–3632. 136 indexed citations
16.
17.
Leung, Wing, Ching‐Hon Pui, Elaine Coustan‐Smith, et al.. (2012). Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood. 120(2). 468–472. 132 indexed citations
18.
Pérez‐Martínez, Antonio, Rekha Iyengar, Kwan Gan, et al.. (2010). Blood Dendritic Cells Suppress NK Cell Function and Increase the Risk of Leukemia Relapse after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(5). 598–607. 21 indexed citations
19.
Fujisaki, Hiroyuki, Harumi Kakuda, Noriko Shimasaki, et al.. (2009). Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy. Cancer Research. 69(9). 4010–4017. 471 indexed citations
20.
Leung, Wing, Rekha Iyengar, Victoria Turner, et al.. (2004). Determinants of Antileukemia Effects of Allogeneic NK Cells. The Journal of Immunology. 172(1). 644–650. 323 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Bader Breakdown of academic impact, for papers by John E. Levine Breakdown of academic impact, for papers by Pierre Bordigoni Breakdown of academic impact, for papers by Nancy Bunin Breakdown of academic impact, for papers by Michael A. Pulsipher Breakdown of academic impact, for papers by Chitra Hosing Breakdown of academic impact, for papers by Kirk R. Schultz Breakdown of academic impact, for papers by Christina Peters Breakdown of academic impact, for papers by Peter Dreger Breakdown of academic impact, for papers by Jürgen Finke
Rankless by CCL
2026